FDA NEWS

Analysts see higher drug sales for Cephalon - Forbes
Sales of Cephalon Inc.'s muscle relaxant Amrix and cancer treatment Treanda will likely continue to drive revenue for the Frazer, Pa.-based drug developer, several analysts said Friday. Cephalon has somewhat shifted its focus to Amrix and Treanda
Source: www.forbes.com

Merck cholesterol drug likely delayed until 2013 - Forbes
Merck & Co. said Friday it will probably be 2013 before regulators reconsider approval of the cholesterol drug the company was counting on to rejuvenate sales growth. The Food and Drug Administration rejected the drug in April, saying it needed more
Source: www.forbes.com

FDA says deaths with heart imaging drugs continue - CNBC
WASHINGTON - Despite previous warnings to physicians, drugs used to improve medical images of the heart continue to cause fatal side effects, regulators said Friday. The Food and Drug Administration said that since October it has received four
Source: www.cnbc.com

Concerns remain over heart imaging agents: FDA - Reuters
WASHINGTON (Reuters) - U.S. health regulators remain concerned about the safety of contrast agents used to enhance echocardiogram heart imaging tests, according to Food and Drug Administration documents released on Friday. The products -- which
Source: www.reuters.com

FDA sued for failure to act on risky painkiller - Los Angeles Times
WASHINGTON -- A prescription painkiller sold under such names as Darvon and Darvocet is too risky to stay on the market, a consumer advocacy group argued Thursday in suing the Food and Drug Administration. Public Citizen petitioned the FDA two years
Source: www.latimes.com

Concerns linger over imaging agents: FDA - Reuters
WASHINGTON (Reuters) - U.S. health regulators are still concerned about the safety of imaging contrast agents used for ultrasound and echocardiograph tests, according to Food and Drug Administration documents released on Friday. The contrast products
Source: www.reuters.com

House Vote for More Food Safety Money Praised - Center for Science in Public Interest
The Food and Drug Administration desperately needs the $150 million in new money approved by the House of Representatives last night, particularly the $67 million designated for the Centers for Food Safety and Applied Nutrition. It's good news for
Source: www.cspinet.org

UPDATE: Long Delay Seen For Merck's Cholesterol Drug - CNN Money
Merck & Co. (MRK) was dealt another setback in its attempt to bring a new cholesterol drug to market after U.S. regulators asked for more information, which could delay the drug's launch for five years. News of the delay comes two months after the U
Source: money.cnn.com